Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lamassu Pharma
AddedFeb 17, 2024
UpdatedJun 18, 2026
Lamassu Pharma

Lamassu Pharma

Seed

Lamassu Pharma: A biotech startup driving medical solutions through innovative translational research.

HQ
Durham, NC, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Lamassu Pharma, founded with a mission to accelerate hope and healing, is a biotech startup dedicated to solving unmet medical needs through innovative translational research. The company focuses on bridging the gap between academia and industry to bring transformational treatments to patients more quickly. Their core offerings include developing science-driven, innovative solutions aimed at meeting critical patient needs, particularly in areas where current treatment options are limited.

Notable figures associated with Lamassu Pharma include a team of dedicated physicians, engineers, and translational scientists who are passionate about treating patients like family. The company has garnered attention for its collaborative approach and has established partnerships with key academic and industry players. Lamassu Pharma's impact is marked by its commitment to accelerating the treatment process, thereby aiming to save more lives and improve patient outcomes significantly.

Lamassu Pharma - Similar Companies

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Camino Pharma logo

Camino Pharma

caminopharma.com

Intellimedix logo

Intellimedix

PleoPharma logo

PleoPharma

pleopharma.com

Essential Remedium logo

Essential Remedium

Faze Medicines logo

Faze Medicines

fazemed.com

iQure Pharma logo

iQure Pharma

iqurepharma.com

EIR Pharmaceuticals logo

EIR Pharmaceuticals

Stramsen Biotech logo

Stramsen Biotech

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

Celdara Medical logo

Celdara Medical

Curie.Bio logo

Curie.Bio

curie.bio

Reset Pharmaceuticals logo

Reset Pharmaceuticals

PhagePro logo

PhagePro

phageproinc.com

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

Lamassu Pharma - Quick Facts

Who are Lamassu Pharma's competitors?

Companies similar to Lamassu Pharma include Auxilius Pharma, Camino Pharma, Intellimedix and PleoPharma.

When was Lamassu Pharma founded?

Lamassu Pharma was founded in 2018.

Where is Lamassu Pharma's headquarters located?

Lamassu Pharma's headquarters is located in Durham, NC, US.

When was Lamassu Pharma's last funding round?

Lamassu Pharma's most recent funding round was for $2.7M (USD) in April 2020.

How much has Lamassu Pharma raised to-date?

As of Apr 29, 2020, Lamassu Pharma has raised a total of $2.7M (USD).

How many employees does Lamassu Pharma have?

Lamassu Pharma has 6 employees as of Feb 5, 2024.

Lamassu Pharma - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Medical Solutions
Tags
  • Healthtech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified